The Drug Controller General of India (DCGI) has directed regulators to take steps to curb black marketing of remdesivir following a complaint black marketing and overpricing of antiviral drug by certain unscrupulous persons.
The Drug Controller General of India (DCGI) has directed regulators to take steps to curb black marketing of remdesivir following a complaint black marketing and overpricing of antiviral drug by certain unscrupulous persons.